These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 19638151)
1. What is the mechanism for acute hemolysis occurring in some patients after intravenous anti-D therapy for immune thrombocytopenic purpura? Garratty G Transfusion; 2009 Jun; 49(6):1026-31. PubMed ID: 19638151 [No Abstract] [Full Text] [Related]
2. Investigation of whether the acute hemolysis associated with Rh(o)(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model. Gaines AR; Lee-Stroka H; Byrne K; Scott DE; Uhl L; Lazarus E; Stroncek DF Transfusion; 2009 Jun; 49(6):1050-8. PubMed ID: 19220820 [TBL] [Abstract][Full Text] [Related]
3. Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura. Rubinstein PG; Chen YH Am J Hematol; 2008 Aug; 83(8):684-5. PubMed ID: 18508323 [No Abstract] [Full Text] [Related]
15. Efficacy and safety of anti-D given by subcutaneous injection to patients with autoimmune thrombocytopenia. Meyer O; Kiesewetter H; Hermsen M; Salama A Eur J Haematol; 2004 Jul; 73(1):71-2. PubMed ID: 15182342 [No Abstract] [Full Text] [Related]
16. Anti-D: mechanisms of action. Ware RE; Zimmerman SA Semin Hematol; 1998 Jan; 35(1 Suppl 1):14-22. PubMed ID: 9523745 [TBL] [Abstract][Full Text] [Related]